PEAR Pear Therapeutics, Inc. - Class A

Pear Therapeutics Inc is engaged in developing and commercializing software-based medicines, called prescription digital therapeutics. It focuses to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.

$1.57  +0.03 (1.95%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Health Information Services
Index country:  USA
Country of incorporation:  
IPO date:  03/31/2021
Outstanding shares:  138,101,541
Average volume:  387,511
Market cap:   $212,676,373
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -3.29
PB ratio:   3.06
PS ratio:   22.46
Return on equity:   -213.64%
Net income %:   -1,568.28%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy